- Home
- CRNT vs ATYR Comparison
CRNT vs ATYR Comparison
Compare CRNT & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNT
- ATYR
- Stock Information
- Founded
- CRNT 1996
- ATYR 2005
- Country
- CRNT Israel
- ATYR United States
- Employees
- CRNT N/A
- ATYR N/A
- Industry
- CRNT Radio And Television Broadcasting And Communications Equipment
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CRNT Technology
- ATYR Health Care
- Exchange
- CRNT Nasdaq
- ATYR Nasdaq
- Market Cap
- CRNT 218.8M
- ATYR 535.0M
- IPO Year
- CRNT 2000
- ATYR 2015
- Fundamental
- Price
- CRNT $2.03
- ATYR $1.02
- Analyst Decision
- CRNT Strong Buy
- ATYR Buy
- Analyst Count
- CRNT 4
- ATYR 5
- Target Price
- CRNT $5.50
- ATYR $19.33
- AVG Volume (30 Days)
- CRNT 542.5K
- ATYR 12.2M
- Earning Date
- CRNT 11-12-2025
- ATYR 11-06-2025
- Dividend Yield
- CRNT N/A
- ATYR N/A
- EPS Growth
- CRNT 34.68
- ATYR N/A
- EPS
- CRNT 0.15
- ATYR N/A
- Revenue
- CRNT $380,518,000.00
- ATYR N/A
- Revenue This Year
- CRNT N/A
- ATYR $420.85
- Revenue Next Year
- CRNT $7.19
- ATYR $1,919.44
- P/E Ratio
- CRNT $13.32
- ATYR N/A
- Revenue Growth
- CRNT 5.06
- ATYR N/A
- 52 Week Low
- CRNT $1.82
- ATYR $1.00
- 52 Week High
- CRNT $5.73
- ATYR $7.29
- Technical
- Relative Strength Index (RSI)
- CRNT 49.93
- ATYR 21.73
- Support Level
- CRNT $1.97
- ATYR $5.08
- Resistance Level
- CRNT $2.07
- ATYR $6.50
- Average True Range (ATR)
- CRNT 0.06
- ATYR 0.47
- MACD
- CRNT 0.02
- ATYR -0.26
- Stochastic Oscillator
- CRNT 71.43
- ATYR 0.27
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.